Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
INMD
STRONG BUYFLAGInMode Ltd. · Healthcare · Israel · $872M · Avg Vol: $9M/d
InMode makes aesthetic medical devices, holds a very large net-cash position and remains profitable with a good quality score (Q74), but revenue has been declining for several consecutive periods as practitioners defer equipment purchases under higher financing costs. That deterioration is the dominant fact and it is not captured by trailing scores. No fraud or distress event is known, so this is a flag.
COMPANY DESCRIPTION
InMode Ltd. develops, manufactures, and markets a range of minimally invasive aesthetic medical devices that utilize proprietary radio-frequency (RF) technology for skin remodeling, fat reduction, and other cosmetic procedures. The company's competitive moat is derived from its innovative, patented technology and focus on less invasive solutions, positioning it as a fast-growing player driving advancements in the global medical aesthetics market.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 454.3M | 492.0M | 394.8M | 370.5M | -6.6% | 374.6M | 370.1M | 378.9M | 1.1% |
| EPS | 1.96 | 2.37 | 2.29 | 1.45 | -9.6% | 1.21 | 1.16 | 1.28 | -6.2% |
| Shares | 82.5M | 84.0M | 69.6M | 63.4M | -23.2% | 57.5M | — | — | — |
| Debt | 5.0M | 9.0M | 7.8M | 8.2M | 18.4% | 4.5M | — | — | — |
| Equity | 554.6M | 787.4M | 703.8M | 683.2M | 7.2% | — | — | — | — |
| Op CF | 181.6M | 176.8M | 132.7M | 85.3M | -22.3% | 83.6M | — | — | — |
| Inv CF | -109.5M | -136.1M | 162.2M | 186.0M | — | — | — | — | — |
| Fin CF | -41.1M | 5.5M | -282.8M | -126.1M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of INMD are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| INMD | InMode Ltd.(you) | $872M | 94 | STRONG BUY |
| 1696.HK | Sisram Medical Ltd | $134M | 88 | STRONG BUY |
| BWAY | BrainsWay Ltd. | $641M | 51 | HOLD |
| KMDA | Kamada Ltd. | $407M | 83 | STRONG BUY |
| CGEN | Compugen Ltd. | $216M | 98 | STRONG BUY |
| NNOX | Nano-X Imaging Ltd. | $62M | 8 | STRONG SELL |
| DRTS | Alpha Tau Medical Ltd. | $1.1B | 26 | SELL |
| SLGL | Sol-Gel Technologies Ltd. | $268M | 33 | SELL |
| BVC.L | BATM Advanced Communications Ltd. | $67M | 51 | HOLD |
| TEVAN.MX | Teva Pharmaceutical Industries Limited | $36.7B | 74 | BUY |
Peer medians: ROE -2.9% · P/E 20.4x · Gross margin 26.1%